Hepatitis B: all 1,662 studies
Page 13 of 17. Open to participants first (192), then studies with results posted, then the rest; newest registration first within each.
- Prevention of Hepatitis B Virus Mother-to-child Transmission by Serovaccination.CompletedNCT01810835
- Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot StudyStatus unknownNCT01804387Phase 4
- HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis BActive, not recruitingNCT01796457
- An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) AnaloguesTerminatedNCT01794234
- Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B VirusCompletedNCT01788371Phase 4
- Acceptability of Hepatitis B Vaccination in General PopulationCompletedNCT01782794
- Acceptability of Hepatitis B Vaccination in General Practitioners and PaediatriciansCompletedNCT01777074
- Comparison of the Efficacy of Entecavir and Tenofovir Monotherapy for the Treatment of Nucleos(t)Ide-naïve Patients With Chronic Hepatitis B in KoreaStatus unknownNCT01776814
- Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in IndiaCompletedNCT01772121
- HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside MaintenanceStatus unknownNCT01769833Phase 3
- Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based ImmunochemotherapyStatus unknownNCT01768195Phase 4
- Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With LymphomaStatus unknownNCT01765231Phase 4
- Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis BCompletedNCT01760122Phase 3
- Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis BCompletedNCT01743079Phase 4
- An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis BCompletedNCT01734018
- TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNACompletedNCT01732367Phase 4
- Study for Consolidation Period of Chronic Hepatitis BCompletedNCT01732354
- To Compare the Efficacy of Combined Tenofovir Plus Telbivudine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis BCompletedNCT01732224Not applicable
- "Real-life" Cohort of Patients With Chronic Hepatitis B Virus InfectionStatus unknownNCT01732081
- An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis BCompletedNCT01730508
- Tenofovir in Asian Chronic Hepatitis B PatientsCompletedNCT01728935Not applicable
- A Study to Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384)WithdrawnNCT01727271Phase 4
- Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in ChinaCompletedNCT01726439
- Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous TreatmentStatus unknownNCT01724723Phase 4
- Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver CirrhosisStatus unknownNCT01720238
- Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV TreatmentTerminatedNCT01715987
- Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to EntecavirCompletedNCT01711567Phase 4
- Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal DysfunctionCompletedNCT01708889Phase 1
- A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis BCompletedNCT01705704
- Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFαTerminatedNCT01694264Phase 3
- Improving Blood Safety and HIV Testing in BrazilCompletedNCT01681420Not applicable
- Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis BCompletedNCT01679769
- A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis BCompletedNCT01671787Phase 1
- A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265CompletedNCT01645969
- Prevalence of Hepatitis B Infection in the Galilee Region, IsraelWithdrawnNCT01645007
- Tolerability, Immunogenicity and Efficacy of HB-110 Administered by Electroporation in Chronic Hepatitis B PatientsCompletedNCT01641536Phase 1
- Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular CarcinomaCompletedNCT01641276Not applicable
- Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis BCompletedNCT01639092Phase 4
- Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis BCompletedNCT01639066Phase 4
- ST-2; a Non-invasive Fibrosis Marker for Chronic Hepatitis BStatus unknownNCT01633554
- Efficacy of Short-term Immunosuppressive Therapy and Anti-allergenic Therapy in Severe Acute Exacerbation of Chronic Hepatitis BStatus unknownNCT01627236Not applicable
- Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute ExacerbationTerminatedNCT01627223Phase 4
- Optimization of Antiviral Therapy of Chronic HBV InfectionCompletedNCT01623778
- HBV DNA Levels During Pregnancy in Chronic Hepatitis BStatus unknownNCT01610115
- Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous InjectionCompletedNCT01606163Phase 1
- Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg LossStatus unknownNCT01599130Not applicable
- Antiviral Efficacy of Switching to ETV Plus TDFStatus unknownNCT01597934Phase 4
- Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis BCompletedNCT01595685Phase 3
- Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination TherapyStatus unknownNCT01595633Phase 4
- Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus InfectionStatus unknownNCT01594905Phase 4
- A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus InfectionCompletedNCT01590654Phase 1
- A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis BCompletedNCT01590641Phase 1
- Registry Study for Patients With Chronic HBV Receiving Nucleotide TherapyCompletedNCT01590615
- Assessment of HBV Vaccine Immunity After 18 YearsStatus unknownNCT01590381
- Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB)Status unknownNCT01589952Phase 1/2
- Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With EntecavirStatus unknownNCT01588912Phase 4
- Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis BCompletedNCT01581554
- Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus LamivudineCompletedNCT01580202Phase 3
- Seroepidemiologic Study of Spermatozoal Transmission of Hepatitis B Virus (HBV)CompletedNCT01574521
- Dose of Hepatitis B Vaccines in Non/Low-response PopulationsCompletedNCT01564134Not applicable
- Resistance to Lamivudine in HBV Egyptian PatientsCompletedNCT01548820
- Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B VaccineStatus unknownNCT01548326Phase 4
- Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)CompletedNCT01546116Phase 4
- Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHBCompletedNCT01532843Phase 4
- A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated InterferonCompletedNCT01531166
- Hepatitis B Vaccine in Patients With Inflammatory Bowel DiseaseCompletedNCT01531075Not applicable
- EFFORT Extension StudyStatus unknownNCT01529255Phase 4
- Tenofovir in Chronic Hepatitis B With Mild ALT ElevationCompletedNCT01522625Phase 4
- A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation RecipientsCompletedNCT01513850Phase 3
- Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective StudyCompletedNCT01502397
- Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B VirusCompletedNCT01500265
- Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B PatientsStatus unknownNCT01491295Phase 4
- Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B VirusCompletedNCT01488526Phase 4
- Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B PatientsStatus unknownNCT01487876Phase 2
- Risk of Hepatitis B Reactivation After Bone Marrow Transplantation With Prior Hepatitis B Virus (HBV) ExposureCompletedNCT01481649
- Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese SubjectsCompletedNCT01480622Phase 1
- Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) InfectionCompletedNCT01480492Not applicable
- HBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon TreatedCompletedNCT01471535Not applicable
- Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of AgeCompletedNCT01470287Phase 3
- A Study of Switch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/mlStatus unknownNCT01464281Not applicable
- Cohort of Hepatitis B Research of AmsterdamStatus unknownNCT01462981
- Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio VaccineCompletedNCT01457560Phase 3
- Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination CourseCompletedNCT01457547Phase 4
- Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered SeparatelyCompletedNCT01457508Phase 3
- Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered ConcomitantlyCompletedNCT01457495Phase 2
- HBsAg Related Response Guided TherapyStatus unknownNCT01456312Phase 4
- Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-respondersStatus unknownNCT01451801Phase 4
- Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B VaccinationStatus unknownNCT01441609
- Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive PatientsStatus unknownNCT01437475Not applicable
- Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B PatientsStatus unknownNCT01436539Phase 4
- Bioequivalence of LB80380 Free Base and Maleate Salt TabletsCompletedNCT01427868Phase 1
- Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver TransplantationCompletedNCT01421212Phase 1/2
- Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ MothersCompletedNCT01412567Not applicable
- Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B StudyCompletedNCT01401400
- Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)Status unknownNCT01380951Phase 4
- Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)CompletedNCT01376154
- NASVAC Phase-III Trial in Chronic Hepatitis B (CHB) PatientsStatus unknownNCT01374308Phase 3
- PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B PatientsCompletedNCT01373684Phase 4
- Prediction of Incidence of Liver Cancer by Use of Real-time Tissue ElastographyStatus unknownNCT01360892
- Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver DiseaseStatus unknownNCT01360879